CRIS Current Research Information System

VIALE, PIERLUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 29.198
NA - Nord America 28.312
EU - Europa 23.373
SA - Sud America 1.992
Continente sconosciuto - Info sul continente non disponibili 1.768
AF - Africa 1.326
OC - Oceania 98
AN - Antartide 1
Totale 86.068
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.639
SG - Singapore 8.031
CN - Cina 7.365
IT - Italia 6.952
VN - Vietnam 6.821
GB - Regno Unito 4.348
DE - Germania 2.724
NL - Olanda 2.208
HK - Hong Kong 1.967
SE - Svezia 1.915
BR - Brasile 1.400
IN - India 1.245
FR - Francia 1.185
KR - Corea 1.017
RU - Federazione Russa 940
BD - Bangladesh 761
IE - Irlanda 630
FI - Finlandia 534
JP - Giappone 517
UA - Ucraina 395
CI - Costa d'Avorio 373
CA - Canada 340
ZA - Sudafrica 335
AR - Argentina 243
BG - Bulgaria 226
ID - Indonesia 213
CH - Svizzera 212
TG - Togo 212
EE - Estonia 200
AT - Austria 178
JO - Giordania 167
PH - Filippine 167
ES - Italia 139
TH - Thailandia 135
MX - Messico 134
IQ - Iraq 127
PL - Polonia 103
BE - Belgio 96
TR - Turchia 96
TW - Taiwan 96
SC - Seychelles 91
AU - Australia 86
PK - Pakistan 83
NG - Nigeria 81
EC - Ecuador 72
SA - Arabia Saudita 68
CL - Cile 63
CO - Colombia 60
RO - Romania 55
LT - Lituania 49
MY - Malesia 46
PE - Perù 44
IR - Iran 42
PY - Paraguay 41
GR - Grecia 39
UZ - Uzbekistan 38
VE - Venezuela 36
HR - Croazia 35
MA - Marocco 35
JM - Giamaica 34
PT - Portogallo 34
CR - Costa Rica 32
CD - Congo 27
EG - Egitto 27
AE - Emirati Arabi Uniti 26
CZ - Repubblica Ceca 26
TN - Tunisia 26
DK - Danimarca 23
LB - Libano 23
DZ - Algeria 21
KE - Kenya 19
GT - Guatemala 18
HN - Honduras 18
NP - Nepal 18
HU - Ungheria 17
IL - Israele 17
KZ - Kazakistan 17
RS - Serbia 16
SK - Slovacchia (Repubblica Slovacca) 16
AL - Albania 15
AZ - Azerbaigian 15
UY - Uruguay 14
ET - Etiopia 13
PA - Panama 13
BO - Bolivia 12
TT - Trinidad e Tobago 12
NI - Nicaragua 11
OM - Oman 11
PR - Porto Rico 11
DO - Repubblica Dominicana 10
LV - Lettonia 10
BA - Bosnia-Erzegovina 9
AO - Angola 8
BH - Bahrain 8
CY - Cipro 8
EU - Europa 8
LY - Libia 8
MD - Moldavia 8
GH - Ghana 7
MK - Macedonia 7
Totale 84.123
Salva come PNG Salva come JPEG
Città #
Singapore 5.674
Southend 3.841
Ashburn 3.299
Fairfield 2.255
Hefei 1.984
San Jose 1.934
Hong Kong 1.831
Ho Chi Minh City 1.640
Chandler 1.430
Hanoi 1.397
Santa Clara 1.300
Bologna 1.119
Woodbridge 1.032
Seattle 973
Seoul 931
Wilmington 927
Houston 913
Frankfurt am Main 868
Princeton 804
Beijing 766
Cambridge 754
Ann Arbor 737
Boardman 722
Eygelshoven 676
Kerkrade 648
Dublin 623
Dong Ket 612
Milan 604
New York 571
Lauterbourg 539
Los Angeles 530
Council Bluffs 464
Dallas 431
Rome 426
Tokyo 426
Abidjan 373
Helsinki 363
Nanjing 286
Buffalo 277
Westminster 255
Da Nang 243
Padova 227
Berlin 220
Lomé 212
Bengaluru 207
Sofia 206
São Paulo 202
Haiphong 199
Chicago 193
Redondo Beach 191
San Diego 175
Florence 174
Turin 173
Shanghai 171
Amman 163
Jinan 161
Saint Petersburg 146
Guangzhou 139
Nuremberg 137
Munich 133
Bern 129
Naples 127
Jakarta 125
Redmond 124
Shenyang 114
Bremen 112
Changsha 112
Des Moines 103
Lappeenranta 103
Amsterdam 99
Dearborn 97
Nanchang 93
Jacksonville 92
Vienna 92
London 91
Brescia 90
Montreal 90
Phoenix 90
The Dalles 87
Hebei 85
San Francisco 85
Brussels 83
Genoa 81
Verona 79
Orem 78
Redwood City 76
Toronto 76
Hải Dương 72
Modena 72
Tianjin 72
Denver 71
Zhengzhou 71
Biên Hòa 69
Rio de Janeiro 68
Abeokuta 67
Johannesburg 66
Olalla 66
Rimini 66
Atlanta 65
Falkenstein 65
Totale 52.410
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.746
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa ? 1.085
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases] 940
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 561
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 481
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 439
2017 WSES guidelines on colon and rectal cancer emergencies: Obstruction and perforation 430
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 393
Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence 376
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. 366
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 363
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 338
Incidence of hospital-acquired infections due to carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa in critically ill patients in Italy: a multicentre prospective cohort study 335
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 334
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 324
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 321
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients 318
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 309
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 304
Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: Sensitivity and specificity of current guidelines on bone mineral density management 292
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 280
Restriction Factors expression decreases in HIV-1 patients after cART 279
A Case Report of Tolvaptan Therapy for ADPKD Patients with COVID-19. The Need for Appropriate Counselling for Temporary Drug Discontinuation 265
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 265
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 264
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 261
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 259
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 257
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 255
Infections in liver and lung transplant recipients: A national prospective cohort 254
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 254
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 253
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 253
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia 250
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 246
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 246
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 241
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 239
Embracing tensions throughout crises: The case of an Italian university hospital during the COVID-19 pandemic 235
Pathological post-mortem findings in lungs infected with SARS-CoV-2 233
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 232
Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study 231
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 230
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 230
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 224
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 224
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 221
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 221
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 219
Bone and Joint Infections: The Role of Imaging in Tailoring Diagnosis to Improve Patients' Care 219
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 217
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 217
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 217
Chagas Disease in a Non-endemic Country: A Multidisciplinary Research, Bologna, Italy 217
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 215
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 214
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 213
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 213
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study 212
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 205
PET con FDG nella dialisi peritoneale: le prospettive attuali e future 205
A prospective survey of febrile events in hematological malignancies. 205
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 205
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. 204
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 204
A proposal for a comprehensive approach to infections across the surgical pathway 204
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 203
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 203
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 202
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 201
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 201
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 201
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 201
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 200
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 200
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 199
Biopsy for suspected spondylodiscitis. 199
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies 199
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 198
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 196
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 196
Advances in the therapy of bacterial bloodstream infections 196
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 196
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 195
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 195
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 195
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 194
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 193
Plasmodium falciparum malaria in migrants who transited Libya - Where did they contract malaria? 193
Schistosoma mansoni eggs in spleen and lungs, mimicking other diseases 193
Impact of preoperative infection on outcome after liver transplantation 191
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 191
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 191
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 191
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 191
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP 190
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 190
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 190
Efficacy of a Novel Prophylactic Scheme of Fosfomycin Trometamol in Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia: Findings from a Prospective Monocentric Single-Arm Study 189
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 188
Totale 27.413
Salva come PNG Salva come JPEG
Categoria #
all - tutte 239.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.763 0 286 419 579 660 385 245 584 322 745 1.340 1.198
2022/20237.547 756 992 391 991 564 539 255 510 1.327 273 548 401
2023/20243.600 244 419 230 348 309 565 282 278 185 308 208 224
2024/202513.886 558 1.680 1.126 1.095 1.838 738 1.079 544 350 987 1.128 2.763
2025/202636.316 3.117 3.533 2.955 2.708 3.076 2.988 4.567 1.415 6.057 2.501 1.870 1.529
2026/20271.741 1.132 609 0 0 0 0 0 0 0 0 0 0
Totale 86.068